Breaking the Mould – GlaxoSmithKline
Breaking the Mould – GlaxoSmithKline
Russ Mould, AJ Bell's Investment Director, discusses GlaxoSmithKline, due to release its first-half results on 24 July, along with the latest central bank decisions on monetary policy.